NeuroVive and Sihuan Pharmaceutical have entered a collaboration agreement to develop and commercialize CicloMulsion® and NeuroSTAT® in China. Sihuan will handle clinical development, regulatory approval, and marketing in China, while NeuroVive will supply the drugs. The agreement includes milestone payments and royalties for NeuroVive.
documents/EFTA01113072.pdf
{}